Dr Reddys Laboratories Ltd Share Price Today - Live Blog for June 01, 2026

Dr Reddys Laboratories Ltd's share price has fallen by -1.09%, a situation worth noting. At present, the stock is trading at 1289.30. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 26.1600, while the industry PE ratio is 33.7338.

The stock of Dr Reddys Laboratories Ltd is facing a -1.08% decline and is currently trading at 1289.40 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd shares experienced a -1.08% reduction, with the current market price at 1289.40. Investors are carefully considering their positions and seeking insights into the stock's future performance.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -1.14% in its share price, and it currently trades at 1288.70 per share. The stock has an ROE of 11.0737 and debt to equity ratio of 0.2041.

Dr Reddys Laboratories Ltd witnessed a -1.14% drop in its share price and is currently trading at 1288.70. With the stock's PE at 26.1600 and the industry PE at 33.7338, investors are weighing their options.

Dr Reddys Laboratories Ltd shares saw a -1.01% decrease, reaching a current market price of 1290.30. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 26.1600, an ROE of 11.0737 and a debt to equity ratio of 0.2041.

With a -1.01% decrease, Dr Reddys Laboratories Ltd's share price is now at 1290.30. The stock is currently trading at a PE of 26.1600, while the industry PE is 33.7338, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd shares experienced a -0.08% reduction, with the current market price at 1302.50. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The share price of Dr Reddys Laboratories Ltd experienced a -0.08% slump and is currently trading at 1302.50. While the stock maintains a PE ratio of 26.1600, the industry PE is 33.7338, raising questions about valuation.

There was no change in the share price of Dr Reddys Laboratories Ltd, and it continues to trade at 1303.50. The stock has a PE ratio of 26.1600, an ROE of 11.0737, and a debt to equity ratio of 0.2041.

Dr Reddys Laboratories Ltd displayed no price movement, holding steady at 1303.50. Interestingly, the stock maintains a Price-to-Earnings (PE) ratio of 26.1600, while the industry PE ratio stands at 33.7338, which might influence investors' decisions.